Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs.The objective of this study was to assess the attitudes toward placebo-controlled clin...
Main Authors: | Norio Sugawara, Masamichi Ishioka, Shoko Tsuchimine, Koji Tsuruga, Yasushi Sato, Hanako Furukori, Shuhei Kudo, Tetsu Tomita, Taku Nakagami, Norio Yasui-Furukori |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4658191?pdf=render |
Similar Items
-
Effect of age and disease on bone mass in Japanese patients with schizophrenia
by: Sugawara Norio, et al.
Published: (2012-02-01) -
The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
by: Kudo S, et al.
Published: (2015-10-01) -
No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
by: Sugawara Norio, et al.
Published: (2012-09-01) -
Body composition in patients with schizophrenia: Comparison with healthy controls
by: Sugawara Norio, et al.
Published: (2012-05-01) -
Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
by: Shoko Tsuchimine, et al.
Published: (2013-01-01)